AtriCure Financials

ATRC Stock  USD 33.78  0.47  1.41%   
Based on the measurements of operating efficiency obtained from AtriCure's historical financial statements, AtriCure may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, AtriCure's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 639.8 M, whereas Retained Earnings are projected to grow to (381.7 M). Key indicators impacting AtriCure's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.150.166
Moderately Down
Pretty Stable
Current Ratio3.813.6477
Sufficiently Up
Slightly volatile
Investors should never underestimate AtriCure's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor AtriCure's cash flow, debt, and profitability to make informed and accurate decisions about investing in AtriCure.

Net Income

(42.46 Million)

  
Understanding current and past AtriCure Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AtriCure's financial statements are interrelated, with each one affecting the others. For example, an increase in AtriCure's assets may result in an increase in income on the income statement.

AtriCure Earnings Geography

Please note, the presentation of AtriCure's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AtriCure's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AtriCure's management manipulating its earnings.

AtriCure Stock Summary

AtriCure competes with AngioDynamics, LeMaitre Vascular, CONMED, and Axogen. AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company was incorporated in 2000 and is headquartered in Mason, Ohio. Atricure operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 875 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS04963C2098
CUSIP04963C209
LocationOhio; U.S.A
Business Address7555 Innovation Way,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.atricure.com
Phone513 755 4100
CurrencyUSD - US Dollar

AtriCure Key Financial Ratios

AtriCure Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets714.5M615.3M585.4M613.9M609.3M639.8M
Retained Earnings(330.4M)(280.2M)(326.6M)(357.1M)(401.8M)(381.7M)
Other Assets16.5M955K2.0M1.00.90.86
Total Liab302.1M131.6M128.7M147.8M148.4M83.9M
Other Current Liab28.5M34.6M36.4M44.7M45.6M47.9M
Accounts Payable12.7M18.6M19.9M27.4M25.0M26.3M
Cash41.9M43.7M58.1M84.3M122.7M128.9M
Inventory35.0M39.0M45.9M67.9M75.3M79.1M
Other Current Assets4.3M5.0M5.5M8.6M9.4M9.9M
Common Stock45K46K47K48K49K29.3K
Net Debt32.1M32.0M11.0M(9.8M)(46.2M)(43.9M)
Net Receivables23.1M33.0M42.7M52.5M60.3M63.4M
Total Current Assets306.7M196.1M215.2M266.2M267.8M281.2M
Long Term Debt53.4M59.7M56.8M60.6M61.9M65.0M
Short Term Debt6.7M1.8M2.1M2.5M2.8M2.3M
Intangible Assets128.2M43.0M39.3M64.0M56.5M38.1M
Other Liab186.4M187.4M1.2M1.2M1.4M1.3M
Net Tangible Assets(117.3M)49.4M206.0M182.6M210.0M220.5M
Long Term Debt Total59.6M53.4M59.7M56.8M65.4M34.9M
Capital Surpluse529.7M742.4M764.8M787.4M905.5M470.9M

AtriCure Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense4.9M4.9M5.0M6.9M6.4M6.7M
Total Revenue206.5M274.3M330.4M399.2M465.3M488.6M
Gross Profit149.3M205.9M245.9M300.4M347.5M364.9M
Operating Income(44.2M)(47.3M)(42.7M)(26.7M)(40.0M)(38.0M)
Ebit(44.2M)(47.3M)(42.7M)(22.9M)(37.3M)(35.4M)
Ebitda(34.7M)(36.9M)(31.0M)(8.1M)(18.5M)(19.5M)
Cost Of Revenue57.2M68.5M84.4M98.9M117.8M123.7M
Net Income(48.2M)50.2M(46.5M)(30.4M)(44.7M)(42.5M)
Income Tax Expense114K188K268K591K1.0M798.3K
Research Development43.1M48.5M57.3M73.9M96.2M101.0M
Income Before Tax(48.0M)50.4M(46.2M)(29.8M)(43.7M)(41.5M)
Tax Provision114K188K268K591K1.0M1.1M
Interest Income1.1M466K2.0M3.8M4.4M4.7M
Net Interest Income(3.8M)(4.5M)(3.0M)(3.1M)(2.0M)(2.1M)

AtriCure Key Cash Accounts

202020212022202320242025 (projected)
Capital Expenditures5.3M9.8M16.9M42.0M23.5M24.6M
End Period Cash Flow41.9M43.7M58.1M84.3M122.7M128.9M
Change To Inventory(5.3M)(4.3M)(7.3M)(21.8M)(7.7M)(7.4M)
Change In Cash13.5M1.7M14.4M26.2M38.4M40.3M
Free Cash Flow(25.1M)(23.5M)(39.0M)(37.5M)12.2M12.8M
Depreciation9.5M10.4M11.7M14.8M18.7M19.7M
Other Non Cash Items1.2M(182.4M)2.7M2.6M12.2M12.8M
Net Income(48.2M)50.2M(46.5M)(30.4M)(44.7M)(42.5M)
Investments(151.7M)33.3M60.9M21.8M30.2M31.7M
Change Receivables(3.2M)5.1M(10.1M)(9.0M)(8.1M)(7.7M)
Net Borrowings19.7M(35K)3.8M(899K)(1.0M)(982.2K)
Dividends Paid25.8M3.9M14.2M12.4M6.0M60K
Change To Netincome13.8M23.6M(72.8M)29.5M26.6M27.9M

AtriCure Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AtriCure's current stock value. Our valuation model uses many indicators to compare AtriCure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AtriCure competition to find correlations between indicators driving AtriCure's intrinsic value. More Info.
AtriCure is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At present, AtriCure's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AtriCure's earnings, one of the primary drivers of an investment's value.

AtriCure's Earnings Breakdown by Geography

AtriCure Systematic Risk

AtriCure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AtriCure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on AtriCure correlated with the market. If Beta is less than 0 AtriCure generally moves in the opposite direction as compared to the market. If AtriCure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AtriCure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AtriCure is generally in the same direction as the market. If Beta > 1 AtriCure moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in AtriCure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AtriCure's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of AtriCure growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.7)

At present, AtriCure's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.

AtriCure March 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of AtriCure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AtriCure. We use our internally-developed statistical techniques to arrive at the intrinsic value of AtriCure based on widely used predictive technical indicators. In general, we focus on analyzing AtriCure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AtriCure's daily price indicators and compare them against related drivers.

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets